The contaminated site and plant modernisation at the same time, balancing investment with environmental legacy
Client: chemical manufacturer in the paints and coatings sector |
The situation
Historical site contamination does not have to block a new investment, but it requires precise planning of how remediation proceedings, new permits and the construction timeline can run in parallel without blocking each other. The problem was that the investment site included two historically contaminated areas. Added to this were complex water and waste obligations, and significant business pressure, the investment had to move forward on a fixed timeline.
Our role
We were leading the strategic EIA process for the expansion and modernisation, synchronising the investment timeline with historically contaminated land covered by the waiver from remediation.
The result
The modernisation project was proceeding on schedule despite the complexity of the regulatory environment. The case illustrates one of the most demanding scenarios in environmental practice: when investment time pressure, contamination legacy covered by the waiver from remediation and new regulations must all be managed simultaneously, with no option to pause any of them.
Planning an investment on a historically contaminated site? We can help map out the regulatory pathway.
Environmental protection
Environmental regulations affect not only compliance, but what matters most in business: the pace of investment, operating costs, and security. In this area, knowing what the law says is not enough. You also need to know how to translate it into concrete actions and sound decisions.
More
They may be interested you
I want to obtain biological material for research purposes, should I consider the Convention on Biological Diversity and the Nagoya Protocol?
Client Global chemicals and Life Sciences group The situation The Convention on Biological Diversity and the Nagoya Protocol on access to genetic r...
Case study Product law
I want to obtain biological material for research purposes, should I consider the Convention on Biological Diversity and the Nagoya Protocol?Trade Inspection is challenging my product compliance- how do I defend myself in proceedings and limit my risk?
Client Operator of a discount store chain with a wide non-food assortment The situation Growing EU regulatory requirements on product safety, label...
Case study Product law
Trade Inspection is challenging my product compliance- how do I defend myself in proceedings and limit my risk?The EU plans to ban PFAS in my products under REACH – how do I build an advocacy strategy and secure an exemption or transition period?
Client Global manufacturer in the technology and industrial sector The situation The pan-European REACH restriction proposal on PFAS covering all n...
Case study Product law
The EU plans to ban PFAS in my products under REACH – how do I build an advocacy strategy and secure an exemption or transition period?See all
Do you need legal support for an investment or product?
Write or call – we'll answer you specifically
and without unnecessary theory.